Filing Details

Accession Number:
0000905148-24-000976
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-19 16:12:27
Reporting Period:
2024-03-15
Accepted Time:
2024-03-19 16:12:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1704292 Zai Lab Ltd ZLAB Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1835780 Iii Titus Frazor Edmondson C/O Zai Lab Limited
314 Main Street, 4Th Floor, Suite 100
Cambridge MA 02142
Chief Legal Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
American Depositary Shares Disposition 2024-03-15 10,000 $18.71 20,005 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
  2. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2023.
  3. Reflects a weighted average sale price of $18.7127 per share, at prices ranging from $18.40 to $19.27 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.